REPORT DESCRIPTION
Adipose Derived Stem Cell Therapy Market – Overview
Adipose derived stem cells (ADSCs) are stem cells derived from adipocytes, and can differentiate into
variety of cell types. ADSCs have multipotency similar to bone marrow mesenchymal stem cells, thus
ADSCs substitute for bone marrow as a source of stem cells. Numerous manual and automatic stem cell
separation procedures are adopted in order to separate adipose stem cells (ASCs) from adipose tissue. Flow
cytometry can also be used to isolate ADSCs from other stem cells within a cell solution.
Adipose derived stem cells are gaining appeal as a new cell source in regenerative medicine therapies as it
can be differentiated into a variety of different cell lineages. These stem cells also have anti-apoptotic, anti-
inflammatory, pro-angiogenic, immunomodulatory, and anti-scarring properties, which enhances its
effectiveness.
High effectiveness of adipose derived stem cell therapy in various medical and biotechnology research
fields coupled with growing research and development activities by various research organizations is
expected to boost the adoption of adipose-derived stem cell therapy in the market during the forecast
period.